The research about the significance of urinary titin in cardiomyopathy

The research about the significance of urinary titin in cardiomyopathy - Urinary titin in cardiomyopathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026641

Enrollment

Registered

2017-03-22

Start date

2017-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) The inpatients and outpatients of the department of cardiovascular medicine in Kobe university hospital, who have cardiomyopathy, such as dilated cardiomyopathy, hypertrophic cardiomyopathy, ischemic cardiomyopathy, congenital heart disease, and normal control. (2) The participants with written consent.

Exclusion criteria

Exclusion criteria: The patients with myodegeneration diseases such as muscular dystrophy. The patients after vigorous exercise or intramuscular injection such that the serum creatine kinase would be elevated . The person who had a proposal of the cancellation about using samples for this study.

Design outcomes

Primary

Measure	Time frame
The concentration of urinary titin	—

Secondary

Measure	Time frame
Diagnosis, sex, age, height, weight, family history, past illness, classification of NYHA, symptom, blood pressure, pulse rate, WBC, RBC, Hb, Plt, TP, Alb, AST, ALT, CK, Na, K, Cl, BUN, Cr, eGFR, BNP, urinary protein, urinary glucose, urinary RBC, %EF, IVST, PWT	—

Countries

Japan

Contacts

Public ContactMatsumoto Kensuke

Department of Internal Medicine, Kobe University Graduate School of Medicine Division of cardiovascular medicine

kenmatsu@med.kobe-u.ac.jp0783825846

Outcome results